Recipharm

Can COVID-19 push us towards the unthinkable: a patent-free vaccine or patent-free drug?

The share savings programme had a positive effect on employee retention, while also increasing the sense of ownership and…

The new facility that will be established in Dehradun, Uttarakhand, in northern India, is expected to be fully operational by 2022…

During a panel discussion, experts discussed about new technologies, challenges in incorporating quality and compliance. It was…

During the panel discussion experts discusses about New technologies: Challenges in incorporating quality and compliance. It was…

Swedish Recipharm has been on an acquisition spree, buying out Italian CDMO, Mitim Srl in February, and completing acquisition of…

Swedish Recipharm has been on an acquisition spree, buying out Italian CDMO, Mitim Srl in February, and completing acquisition of…

Signs two separate strategic agreements in India, US and Sweden Recipharm has signed two separate agreements to acquire Kemwell’s…

Recipharm acquires 74 per cent of the shares for a purchase consideration of Rs 6,713 million on a cash and debt free basis

The former will acquire 74  per cent of the shares for an estimated purchase consideration of Rs 6,712 million on a cash and debt…